Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robots take on IBD: can High-Tech surgery improve outcomes?

NCT ID NCT06579443

Knowledge-focused Sponsor: University Hospitals Coventry and Warwickshire NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether robotic surgery is a practical option for people with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Researchers will compare robotic surgery to standard laparoscopic surgery in 100 adults to see which approach works better. The goal is to find the best surgical setup and measure outcomes like blood loss, operation time, and recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
robotic surgery
What this could lead to
If successful, this could show that robotic surgery is a safe and effective option for IBD patients, potentially improving recovery and outcomes.
What could go wrong
This is an early feasibility study with only 100 participants, so results may not apply to all IBD patients. Robotic surgery may not offer clear advantages over standard laparoscopic techniques.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing surgery for inflammatory bowel disease

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or over * Undergoing IBD surgery using MIS (minimally invasive surgery) techniques * Histological/radiological evidence of inflammatory bowel disease Exclusion Criteria: * Planned open surgical approach * Lacks capacity to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohn disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Crohn disease Inflammatory bowel diseases Ulcerative colitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    6 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Chelsea and Westminster Hospital NHS Foundation

    RECRUITING

    London, SW10 9NH, United Kingdom

    Contact Email: •••••@•••••

  • Guy's and St Thomas NHS Foundation Trust

    RECRUITING

    London, SE1 7EH, United Kingdom

    Contact Email: •••••@•••••

  • London North West University Healthcare NHS Trust

    RECRUITING

    Harrow, HA1 3UJ, United Kingdom

    Contact Email: •••••@•••••

  • Newcastle Hospitals NHS Foundation Trust

    RECRUITING

    Newcastle upon Tyne, West Midlands, NE7 7DN, United Kingdom

    Contact Email: •••••@•••••

  • Oxford University Hospitals NHS Foundation Trust

    RECRUITING

    Oxford, West Midlands, OX3 9DU, United Kingdom

    Contact Email: •••••@•••••

  • University Hospitals Coventry & Warwickshire (UHCW) NHS Trust

    RECRUITING

    Coventry, West Midlands, CV2 2DX, United Kingdom

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.